Wistar Scientists Develop Novel Immunotherapy Technology for Prostate Cancer
Thursday, August 17, 2017 - 10:02
in Health & Medicine
A study led by Wistar scientists describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein.